Tetraphase Pharmaceuticals Inc (TTPH)

7.35
NASDAQ : Health Care
Prev Close 7.35
Day Low/High 0.00 / 0.00
52 Wk Low/High 3.11 / 9.93
Avg Volume 613.40K
Exchange NASDAQ
Shares Outstanding 37.96M
Market Cap 286.19M
EPS -2.10
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Tetraphase Pharmaceuticals' TP-6076 Selected By CARB-X To Receive $4 Million In Research Funding

Tetraphase Pharmaceuticals' TP-6076 Selected By CARB-X To Receive $4 Million In Research Funding

Funding initiative focused on urgent public health crisis of antibiotic resistance

TTPH Crosses Above Average Analyst Target

TTPH Crosses Above Average Analyst Target

In recent trading, shares of Tetraphase Pharmaceuticals, Inc have crossed above the average analyst 12-month target price of $8.40, changing hands for $8.67/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level.

First Week of August 18th Options Trading For Tetraphase Pharmaceuticals (TTPH)

First Week of August 18th Options Trading For Tetraphase Pharmaceuticals (TTPH)

Investors in Tetraphase Pharmaceuticals, Inc saw new options begin trading this week, for the August 18th expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 186 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week of May 2017 Options Trading For Tetraphase Pharmaceuticals (TTPH)

First Week of May 2017 Options Trading For Tetraphase Pharmaceuticals (TTPH)

Investors in Tetraphase Pharmaceuticals, Inc saw new options begin trading this week, for the May 2017 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 210 days until expiration the newly trading contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

5 Stocks to Trade for Big Breakout Gains

5 Stocks to Trade for Big Breakout Gains

Here's a technical look at how to trade five stocks that are within range of triggering big breakout trades.

Short Interest In Tetraphase Pharmaceuticals Falls 19.4%

Short Interest In Tetraphase Pharmaceuticals Falls 19.4%

The most recent short interest data has been released for the 06/30/2016 settlement date, which shows a 875,721 share decrease in total short interest for Tetraphase Pharmaceuticals, Inc , to 3,645,836, a decrease of 19.37% since 06/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

First Week of February 2017 Options Trading For Tetraphase Pharmaceuticals (TTPH)

First Week of February 2017 Options Trading For Tetraphase Pharmaceuticals (TTPH)

Investors in Tetraphase Pharmaceuticals, Inc saw new options begin trading this week, for the February 2017 expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 240 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Tetraphase Pharmaceuticals Presents Antibiotics Pipeline Data At ASM Microbe 2016

Tetraphase Pharmaceuticals Presents Antibiotics Pipeline Data At ASM Microbe 2016

Includes Phase 3 Clinical Trial Data from IGNITE1 and IGNITE2

Monsanto, Amazon and Apple: Doug Kass' Views

Monsanto, Amazon and Apple: Doug Kass' Views

Doug Kass shares his thoughts on shorting financials, and wonders if it will be a Monsanto merger Monday.